PDGFRB and neoplasm: Additionally, as an alternative model for investigating the role of perivascular cells in tumour revascularization, HT‐29 tumour‐bearing mice were treated with PDGFRβ neutralizing antibodies to deplete vessel‐associated PDGFRβ+ perivascular cells (Figure 1d) (Cooke et al., 2012).